Generic Name: Oxcarbazepine
Trileptal (Tri-LEP-tal) is related to Tegretol, TegretolXR, Carbatrol, and Epitol (carbamazepine). It was developed in an effort to combine the effectiveness of these related drugs with fewer side effects and drug interactions. Trileptal was approved for use in the treatment of epilepsy in 2000. It is used as single drug therapy (monotherapy) and as add-on therapy (adjunctive) in adults and children 4 years of age and older with partial seizures. It tends to be better tolerated than carbamazepine with fewer side effects.
Common side effects include fatigue, headache, dizziness, sleepiness, unsteadiness, nausea, vomiting and double vision. Allergic rashes sometimes develop, but less frequently than with carbamazepine.
Safety in pregnancy has not been established. Women who are taking this medication and who wish to become pregnant should discuss treatment options with their physicians before the pregnancy begins.